{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:59:06Z","timestamp":1792119546269,"version":"4.4.0"},"reference-count":31,"publisher":"Massachusetts Medical Society","issue":"6","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,2,5]]},"DOI":"10.1056\/nejmoa2508668","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T21:00:08Z","timestamp":1761771608000},"page":"551-562","source":"Crossref","is-referenced-by-count":92,"title":["Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer"],"prefix":"10.1056","volume":"394","author":[{"given":"Sara M.","family":"Tolaney","sequence":"first","affiliation":[{"name":"Dana\u2013Farber Cancer Institute, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer, Fifth Medical Center of People\u2019s Liberation Army General Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romualdo","family":"Barroso-Sousa","sequence":"additional","affiliation":[{"name":"Brasilia Hospital, Rede Am\u00e9ricas, Brasilia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[{"name":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mothaffar F.","family":"Rimawi","sequence":"additional","affiliation":[{"name":"Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Saura","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron University Hospital, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[{"name":"National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Toi","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Soo","family":"Chae","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Kyungpook National University Chilgok Hospital, Kyungpook National University School of Medicine, Daegu, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Kemal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Alt\u0131nbas University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Chaudhari","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, HCG Manavata Cancer Center, Mumbai Naka, Nashik, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet A.N.","family":"\u015eendur","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Casalnuovo","sequence":"additional","affiliation":[{"name":"Clinical Oncology Unit, LUCEN, Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Danso","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Brock Cancer Center, Virginia Oncology Associates, Norfolk"},{"name":"Department of Medical Oncology, Brock Cancer Center, Sarah Cannon Research Institute, Norfolk, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Biometrics Oncology, Late-Stage Development, Oncology Research and Development, AstraZeneca, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Shetty","sequence":"additional","affiliation":[{"name":"Late Development Oncology, Clinical Development, Oncology Research and Development, AstraZeneca, Gaithersburg, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Herbolsheimer","sequence":"additional","affiliation":[{"name":"Late Development Oncology, Clinical Development, Oncology Research and Development, AstraZeneca, Gaithersburg, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[{"name":"Johann Wolfgang Goethe Universit\u00e4t, Frankfurt am Main, Germany"},{"name":"German Breast Group, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2023-0950-SA"},{"key":"e_1_3_4_3_2","unstructured":"National Cancer Institute. Cancer stat facts: female breast cancer subtypes (https:\/\/seer.cancer.gov\/statfacts\/html\/breast-subtypes.html)."},{"key":"e_1_3_4_4_2","unstructured":"American Cancer Society. Breast cancer (https:\/\/www.cancer.net\/cancer-types\/breast-cancer\/introduction)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184522"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0446"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00519"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.010"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103756"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113216"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30863-0"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2822"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12966"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c18-00744"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115022"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02420-5"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03021-7"},{"key":"e_1_3_4_18_2","unstructured":"ENHERTU. Basking Ridge NJ: Daiichi Sankyo 2025 (package insert) (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761139s032s035lbl.pdf)."},{"key":"e_1_3_4_19_2","unstructured":"ENHERTU. Munich Germany: Daiichi Sankyo Europe 2025 (package insert) (https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/enhertu-epar-product-information_en.pdf)."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100342"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.1009"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914510"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100553"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-024-07506-4"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae280"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03261-7"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1092"},{"key":"e_1_3_4_28_2","unstructured":"Metzger O. AFT-38 PATINA: a randomized open label phase III trial to evaluate the efficacy and safety of palbociclib + anti-HER2 therapy + endocrine therapy vs. anti-HER2 therapy + endocrine therapy after induction treatment for hormone receptor-positive (HR+)\/HER2-positive metastatic breast cancer. In: Proceedings and Abstracts of the 2024 San Antonio Breast Cancer Symposium December 10\u201313 2024. San Antonio TX: American Association for Cancer Research 2024."},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00725-0"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104163"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203690"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407086"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2508668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:00:44Z","timestamp":1770242444000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2508668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,2,5]]}},"alternative-id":["10.1056\/NEJMoa2508668"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2508668","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}